An increased expression of CD73 has been observed in various cancers, such as non-small-cell lung cancer (NSCLC), gastric, renal, colorectal, and prostate cancers, and melanoma and often correlates with a poor prognosis [10,11,12,13,14,15,16]. This evidence concerns the gene NT5E and non-small cell lung carcinoma.